Biogen and City Therapeutics Forge $1B RNAi PartnershipBiogenBiogen has partnered with RNAi specialist City Therapeutics in a deal worth up to $1 billion to develop next-generation CNS drugs. The collaboration includes milestone payments, equity investment, and clinical development leadership.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
